|
|
||||||||
RESEARCH REPORT |

1 Regenetiss Co., Ltd., 1-5-17, Akabane, Okaya, Nagano 394-0002, Japan;
2 Frontier Research Division, Fujirebio Inc., Hachioji, Tokyo, Japan;
3 Graduate School of Dental Medicine, and
4 Graduate School of Engineering, Hokkaido University, Sapporo, Hokkaido, Japan; and
5 Matsumoto Dental University, Shiojiri, Nagano, Japan;
* corresponding author, shiba{at}regenetiss.com
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: calcification osteoblasts osteopontin osteocalcin polyphosphate
| INTRODUCTION |
|---|
|
|
|---|
| MATERIALS & METHODS |
|---|
|
|
|---|
-MEM), L-glutamine, fetal bovine serum (FBS), and sodium phosphate glass Type 65 (with average chain lengths of 65 phosphate residues) were obtained from Sigma. All non-radioactive poly(P)s used in the experiments were sodium phosphate glass Type 65, and the contamination level of pyrophosphate in this poly(P) is less than 0.01%. Radioactive poly(P) represented as [32P]poly(P) (with a chain length of more than 700 phosphate residues) was synthesized with the use of purified E. coli polyphosphate kinase with [
32P]-ATP and purified as described previously (Ahn and Kornberg, 1990). Polyethyleneimine thin-layer chromatography (PEI-TLC) plates were obtained from Merck. Recombinant yeast-soluble exopolyphosphatase (rPPX1) was overproduced in E. coli and purified as described previously (Wurst et al., 1995). Additional chemicals were purchased from Wako Pure Chemicals Co. (Osaka, Japan). The concentrations of poly(P) are represented in terms of phosphate residues.
Induction of Cell Calcification
MC3T3-E1 cells were plated on 60-mm plastic Petri dishes at a density of 1 x 105 cells/dish and maintained in
-MEM supplemented with 50 µg/mL of kanamycin and 10% FBS at 37°C in a humidified atmosphere of 5% CO2 in air. After the cells had become confluent, the medium was replaced with
-MEM supplemented with either 0.5% FBS and 50 µg/mL kanamycin or with 0.1, 0.5, or 1 mM poly(P), 0.1, 0.5 or 1 mM sodium phosphate buffer or 10 mM of ß-glycerophosphate (ß-GP) and 50 µg/mL of ascorbic acid (AA). The cells were further cultured with or without stimulants, and the medium was replaced every fourth day.
Quantification of mRNA Levels by Real-time PCR
Total RNA was purified with the use of an SV Total RNA Isolation System (Promega, Madison, WI, USA) following the manufacturers instructions. Reverse-transcription reactions were performed with the use of an oligo dT (20 mer) primer and ReverTra AceTM (TOYOBO, Osaka, Japan) according to the manufacturers instructions. The synthesized cDNAs were then used for quantitative PCR analysis with primers for the exon/intron junctions. The sequences of the designed primers and the basic procedures used for quantitative PCR are described in the legend of Fig. 1
.
|
Preparation of Cell Extracts and Determination of Protein Concentration
Cells were trypsinized, collected in micro-tubes, and washed once with 20 mM Tris-HCl (pH 7.5) containing 150 mM NaCl (TBS). The cell pellets were re-suspended in the appropriate buffers used in each assay, and the cells were then ultrasonicated on ice for the preparation of whole-cell extracts. Protein concentrations of both extracts and supernatant fractions were determined by BCA assays (Smith et al., 1987) and Bradford assays (Bradford, 1976), respectively.
Assay for Alkaline Phosphatase (ALPase) Activity
The reaction mixtures contained 50 mM Tris-HCl (pH 8.8), 10 mM MgCl2, 20 mM of p-nitrophenylphosphate (p-NPP), and whole-cell extract (20 µg). Following incubation for appropriate times at 37°C, the absorbance at 405 nm was measured by spectrophotometry, and the specific activity was then determined. One OD405 unit corresponds to a decomposition of 66.6 nM of p-NPP, and one unit represents a decomposition of 1 µmol of p-NPP per min.
Assay for Polyphosphatase [poly(P)ase] Activities
Each reaction mixture (20 µL) contained 20 mM Tris-HCl (pH 7.5), 20 mM (NH4)2SO4, 5 mM MgSO4, 2.4 mM of [32P]poly(P), and a supernatant fraction of ultrasonicated cell extract (20 µg). Following incubation for 8 hrs at 37°C, 2 µL of each reaction mixture was applied to a PEI-TLC plate and developed with 2 M LiCl and 1 M HCOOH.
| RESULTS |
|---|
|
|
|---|
Induction of ALPase Activity by Poly(P)
ALPase activity is commonly used as an indicator of calcification in the matrix maturation phase (Beck et al., 1998), and an experiment was carried out in this study to determine whether poly(P) has an effect on ALPase activity. The level of ALPase activity in poly(P)-treated cells did indeed increase with incubation time, but the magnitude of this increase was less than that in cells treated with ß-GP and AA (a positive control for cell calcification) (Fig. 2
). The fact that no increase in ALPase activity was observed in phosphate-buffer-treated cells or non-treated cells (negative controls for cell calcification) indicates that poly(P) has a positive effect on the induction of ALPase activity.
|
|
Enhancement of Poly(P)ase Activity by Poly(P)
Since relatively high levels of PPX and endopolyphosphatase (PPN) activity were detected in human osteoblasts (Schröder et al., 2000), we measured the levels of poly(P)ase activity in MC3T3-E1 cells that were treated with poly(P), phosphate buffer, and ß-GP and AA. Fig. 4A
shows the results of TLC analysis of poly(P)ase activity during cell calcification treatment. Whole-cell extracts were prepared, and poly(P)ase activities were determined with [32P]poly(P) used as a substrate. In cells treated with poly(P), poly(P)ase activity was enhanced, whereas no enhancement of activity was observed in extracts from cells treated with other reagents. Extracts from poly(P)-treated cells had strong poly(P)ase activities that resulted in the production of low-molecular-weight products and orthophosphate after 11 days of treatment. The maximum level of induced activity was up to six-fold greater than that in non-treated cells, and the levels were gradually decreased but were detectable until 21 days after the start of poly(P) treatment. These results indicate that poly(P) induces poly(P)ase activities, including those of both PPX and PPN, in MC3T3-E1 cells.
|
To determine that the low-molecular-weight products detected between poly(P) (origin) and orthophosphate during TLC analysis (Fig. 4A
, days 11, 16, and 23 in poly(P)-treated cell extracts) are short-chain poly(P) species, we further treated the products of these reactions with purified rPPX1 (Wurst et al., 1995). TLC analysis of reaction products treated with or without rPPX1 showed that the low-molecular-weight products had completely disappeared, and the orthophosphate spot became more pronounced following rPPX1 treatment (Fig. 4B
).
For further identification of the low-molecular-weight products, the products were separated by longer TLC. A pyrophosphate spot (P2) migrated a little below the position of the orthophosphate spot (Pi) (Fig. 4C
). We did not observe any obvious spot in the area corresponding to the pyrophosphate spot in the [32P]poly(P) sample treated with cell extract (day 16) (lane 3). This suggests that the main components of the low-molecular-weight products were larger than tripolyphosphate (P3).
| DISCUSSION |
|---|
|
|
|---|
ALPase activity was also induced during poly(P) treatment but at lower levels than in cells treated with ß-GP and AA. Since Schröder et al.(2000) demonstrated that only the intestinal isoform of ALPase is able to degrade poly(P), whereas placenta-type and tissue-non-specific isoenzymes which are present in bone did not, ALPase may not be involved in poly(P) metabolism in MC3T3-E1 cells. We also demonstrated that PPX and PPN activities were enhanced by poly(P) treatment, which may result in the supply of phosphate to cells for calcification. It had previously been shown that when cells are treated with ß-GP and AA, ß-GP is degraded by the induced ALPase activity (Stein et al., 1996). Elevation of the level of ALPase activity has also been shown to result in the formation of phosphate molecules and the concomitant induction of OPN expression, since high phosphate levels trigger the induction of OPN (Beck et al., 2000). Therefore, poly(P) may work as a phosphate source for the induction of OPN expression in place of ß-GP. Elevated poly(P)ase activity generates free phosphate from poly(P), whereas elevated ALPase activity produces phosphate from ß-GP, and enhancement of poly(P)ase activities may thus compensate for ALPase activity, the level of which is less in poly(P)-treated cells than in ß-GP- and AA-treated cells. Based on this possibility, it can be speculated that poly(P) acts as a phosphate source for cell calcification itself. Since we found that most of the poly(P) in the culture medium binds to the cells (data not shown), polyphosphate may be concentrated and degraded at the surfaces of or inside the cells, and the phosphate concentrations in the cells may be increased. Concentrated poly(P) inside the cell or on the cell surface may cause the condition similar to that when the cells were treated with a large amount of phosphate in culture medium. This condition may induce calcification of MC3T3-E1 cells. In addition, since poly(P)ase can also produce pyrophosphate (PPi), the balance of poly(P), PPi, and Pi levels might be crucial for regulating cell calcification (Terkeltaub, 2001).
We found, in a recent in vitro study, that poly(P) dosage enhanced fibroblast cell growth by stabilizing FGF-1 and FGF-2 and by promoting the binding between FGFs and their receptors (FGFRs) (Shiba et al., 2003). FGFs are also important factors in cell calcification, because both they and their cell-surface receptors are widely distributed in osteoblast and pre-osteoblast cells. Hurley et al. have demonstrated that parathyroid hormone induces the expression of FGF-2 and FGFRs in MC3T3-E1 cells and in osteoblasts in mice calvaria (Hurley et al., 1999). It has also been shown that FGF-2 induced new long-bone formation when injected into bone marrow (Tanaka et al., 1997). These findings suggest that enhancement of FGF activity by poly(P) may be responsible for the promotion of cell calcification.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
present address, Department of Radiological Technology, College of Medical Technology, Hokkaido University, Sapporo, Hokkaido, Japan; Received September 17, 2003; Last revision April 17, 2004; Accepted May 24, 2004
| REFERENCES |
|---|
|
|
|---|
Beck GR Jr, Sullivan EC, Moran E, Zerler B (1998). Relationship between alkaline phosphatase levels, osteopontin expression, and mineralization in differentiating MC3T3-E1 osteoblasts. J Cell Biochem 68:269280.[ISI][Medline]
Beck GR Jr, Zerler B, Moran E (2000). Phosphate is a specific signal for induction of osteopontin gene expression. Proc Natl Acad Sci USA 97:83528357.
Bradford MM (1976). A rapid and sensitive method for the quantitation for microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248254.[ISI][Medline]
Hurley MM, Tetradis S, Huang YF, Hock J, Kream BE, Raisz LG, et al. (1999). Parathyroid hormone regulates the expression of fibroblast growth factor-2 mRNA and fibroblast growth factor receptor mRNA in osteoblastic cells. J Bone Miner Res 14:776783.[ISI][Medline]
Kornberg A (1995). Inorganic polyphosphate: toward making a forgotten polymer unforgettable. J Bacteriol 177:491496.
Kulaev IS (1979). The biochemistry of inorganic polyphosphates. New York, NY, USA: John Wiley & Sons, Inc.
Kulaev IS, Vogabov VM, Kulakovskaya T (1999). New aspects of inorganic polyphospate metabolism and function. J Biosci Bioeng 88:111129.
Kumble KD, Kornberg A (1995). Inorganic polyphosphate in mammalian cells and tissues. J Biol Chem 270:58185822.
Leyhausen G, Lorenz B, Zhu H, Geurtsen W, Bohnensack R, Muller WEG, et al. (1998). Inorganic polyphosphate in human osteoblast-like cells. J Bone Miner Res 13:803812.[ISI][Medline]
Quarles LD, Yohay DA, Lever LW, Caton R, Wenstrup RJ (1992). Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development. J Bone Miner Res 7:683692.[ISI][Medline]
Schröder HC, Kurz L, Muller WEG, Lorenz B (2000). Polyphosphate in bone. Biochemistry (Moscow) 65:353361.
Shiba T, Nishimura D, Kawazoe Y, Onodera Y, Tsutsumi K, Nakamura R, et al. (2003). Modulation of mitogenic activity of fibroblast growth factors by inorganic polyphosphate. J Biol Chem 278:2678826792.
Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, et al. (1987). Measurement of protein using bicinchoninic acid. Anal Biochem 150:7685.
Stein GS, Lian JB, Stein JL, van Wijnen AJ, Montecino M (1996). Transcriptional control of osteoblast growth and differentiation. Physiol Rev 76:593629.
Sudo H, Kodama HA, Amagai Y, Yamamoto S, Kasai S (1983). In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol 96:191198.
Tanaka M, Amizuka N, Kim KJ, Itoh T, Ozawa H (1997). Histochemical examination of ectopic bone formation induced in rat bone marrow. J Bone Miner Metab 15:6776.
Terkeltaub RA (2001). Inorganic pyrophosphate generation and disposition in pathophysiology. Am J Physiol Cell Physiol 281:C1C11.
Wood HG, Clark JE (1988). Biological aspects of inorganic polyphosphates. Ann Rev Biochem 57:235260.[ISI][Medline]
Wurst H, Shiba T, Kornberg A (1995). The gene for a major exopolyphosphatase of Saccharomyces cerevisiae. J Bacteriol 177:898906.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| IADR Journals | Advances in Dental Research ® |
| Journal of Dental Research ® | Critical Reviews (1990-2004) |